We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleConcomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer†.AuthorsXu, C. F.; Xue, Z.; Bing, N.; King, K. S.; McCann, L. A.; de Souza, P. L.; Goodman, V. L.; Spraggs, C. F.; Mooser, V. E.; Pandite, L. N.PublicationAnnals of Oncology, 2012, Vol 23, Issue 9, p2470ISSN0923-7534Publication typearticleDOI10.1093/annonc/mds249